Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-08-19 19:00 |
Valneva Announces Management Board Stock Purchases
|
English | 10.6 KB | ||
| 2019-08-19 18:00 |
Valneva Announces Management Board Stock Purchases
|
English | 266.8 KB | ||
| 2019-08-19 18:00 |
Valneva annonce l'acquisition d'actions par son Directoire
|
French | 268.6 KB | ||
| 2019-08-01 18:00 |
Déclaration d'actions et de droits de vote de la société Valneva SE - Juillet 2…
|
French | 11.6 KB | ||
| 2019-08-01 17:13 |
Valneva rapport semestriel 2019
|
French | 853.1 KB | ||
| 2019-08-01 07:00 |
Valneva: résultats financiers du S1 2019 soutenus par une forte performance opé…
|
French | 963.6 KB | ||
| 2019-08-01 07:00 |
Valneva Reports H1 2019 Results Marked by Strong Operational Performance and Ma…
|
English | 801.1 KB | ||
| 2019-07-11 18:00 |
Déclaration d'actions et de droits de vote de la société Valneva SE - Juin 2019
|
French | 9.5 KB | ||
| 2019-07-09 18:00 |
Bilan Semestriel du contrat de liquidité de Valneva SE
|
French | 1.5 KB | ||
| 2019-07-03 17:45 |
Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor …
|
English | 480.4 KB | ||
| 2019-07-03 17:45 |
Le Dr. Stanley Plotkin, spécialiste mondial des vaccins, participera à la journ…
|
French | 544.7 KB | ||
| 2019-07-02 17:45 |
Valneva dépose une demande de radiation de ses actions ordinaires auprès de la …
|
French | 379.3 KB | ||
| 2019-07-02 17:45 |
Valneva Submits Delisting Application to the Vienna Stock Exchange
|
English | 374.2 KB | ||
| 2019-07-01 17:57 |
Valneva initie la deuxième étude de Phase 2 pour son candidat vaccin contre la …
|
French | 461.8 KB | ||
| 2019-07-01 17:57 |
Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate V…
|
English | 460.6 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
